
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About
Figs Inc (FIGS)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: FIGS (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -74.75% | Avg. Invested days 21 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 763.84M USD | Price to earnings Ratio 229.5 | 1Y Target Price 5.26 |
Price to earnings Ratio 229.5 | 1Y Target Price 5.26 | ||
Volume (30-day avg) 2528063 | Beta 1.26 | 52 Weeks Range 4.18 - 7.05 | Updated Date 04/1/2025 |
52 Weeks Range 4.18 - 7.05 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.02 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 0.49% | Operating Margin (TTM) 5.86% |
Management Effectiveness
Return on Assets (TTM) 0.29% | Return on Equity (TTM) 0.72% |
Valuation
Trailing PE 229.5 | Forward PE 114.94 | Enterprise Value 553879777 | Price to Sales(TTM) 1.37 |
Enterprise Value 553879777 | Price to Sales(TTM) 1.37 | ||
Enterprise Value to Revenue 1 | Enterprise Value to EBITDA 61.82 | Shares Outstanding 154236992 | Shares Floating 148782379 |
Shares Outstanding 154236992 | Shares Floating 148782379 | ||
Percent Insiders 5.42 | Percent Institutions 97.12 |
Analyst Ratings
Rating 3.09 | Target Price 5.69 | Buy 1 | Strong Buy 1 |
Buy 1 | Strong Buy 1 | ||
Hold 7 | Sell 2 | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Figs Inc
Company Overview
History and Background
Figs Inc. was founded in 2013 by Heather Hasson and Trina Spear. They identified a need for more stylish and functional medical apparel. Figs went public in May 2021. They disrupted the traditional medical apparel market by focusing on direct-to-consumer sales, innovative fabrics, and community engagement.
Core Business Areas
- Apparel: Figs primarily sells medical apparel, including scrubs, lab coats, and other workwear designed for healthcare professionals. This is their core revenue driver.
- Lifestyle: Figs also offers lifestyle apparel, such as compression socks, outerwear, and accessories, expanding their brand beyond the medical field.
- Team Sales: Figs offers team sales for medical organizations, providing bulk orders with customized branding and features. This can often be a lucrative area for repeat business for the company.
Leadership and Structure
Figs Inc. is led by CEO Trina Spear. The organizational structure includes departments for product development, marketing, sales, operations, finance, and technology. They have a board of directors overseeing the company's strategic direction.
Top Products and Market Share
Key Offerings
- Core Scrubs: Figs' core scrubs are their most popular product, known for their comfortable, durable, and stylish design. While precise market share data is difficult to obtain, Figs is estimated to be one of the leading scrub brands in the US. Competitors include Careismatic Brands (Cherokee, Dickies), Med Couture, and Jaanuu. Revenue attributed to core scrubs makes up the majority of revenue but figures are unavailable
- Lab Coats: Figs lab coats offer healthcare professionals an improved fit, with stain and anti-microbial features. They also incorporate new technology to address medical safety. Competitors include Landau and Medline. Revenue attributed to lab coats is not publicly available but is likely a smaller percentage than their scrub revenue.
- Lifestyle Apparel: Figs has expanded into lifestyle apparel, including compression socks, outerwear, and accessories. No market share available and competitors are mainstream brands like Nike and Lululemon. The revenue attributed to lifestyle apparel is likely smaller than their scrub revenue.
Market Dynamics
Industry Overview
The medical apparel industry is a growing market driven by the increasing demand for healthcare services and the need for functional and comfortable workwear. It is becoming increasingly fragmented with the rise of direct-to-consumer brands.
Positioning
Figs is positioned as a premium direct-to-consumer brand in the medical apparel market. Their competitive advantages include their innovative fabrics, stylish designs, strong brand image, and direct-to-consumer business model.
Total Addressable Market (TAM)
The global medical apparel market is estimated to be around $60 billion. Figs is positioned to capture a larger share of this market through continued product innovation, market expansion, and brand building.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Innovative product design
- Direct-to-consumer business model
- High customer loyalty
- Data-driven decision making
Weaknesses
- Relatively high price point
- Limited physical retail presence
- Dependence on online sales channels
- Supply chain vulnerabilities
Opportunities
- Expansion into new product categories
- International market expansion
- Strategic partnerships with healthcare organizations
- Increased focus on team sales
- Development of new technologies for medical apparel
Threats
- Increased competition from established players and new entrants
- Changes in consumer preferences
- Economic downturn
- Supply chain disruptions
- Fluctuations in raw material costs
Competitors and Market Share
Key Competitors
- Cintas Corporation (CTAS)
- Careismatic Brands Inc. (Private)
- Jaanuu (Private)
Competitive Landscape
Figs benefits from being a D2C brand. Its innovation puts it ahead of its competitors; however, because it is more expensive, it may be more affected by any economic downturn than Cintas (CTAS) which has more affordable apparel.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Figs has experienced significant revenue growth in recent years, driven by increased brand awareness, product innovation, and expansion of its customer base.
Future Projections: Analyst estimates suggest continued revenue growth for Figs, fueled by its strong brand, innovative products, and expansion into new markets and product categories.
Recent Initiatives: Recent strategic initiatives undertaken by Figs include expanding its lifestyle apparel offerings, focusing on team sales, and investing in its supply chain.
Summary
Figs is a growing brand in medical apparel known for innovative fabric, style and a D2C approach. The brand has a strong following from its customers. As the brand expands into new categories it can capitalize on a wider audience of consumers. An economic downturn might affect the brand's higher pricing. More competition from established players may be a future challenge.
Similar Companies
- LULU
- CTAS
- VNT
- WWD
Sources and Disclaimers
Data Sources:
- Company SEC Filings
- Market Research Reports
- Analyst Estimates
Disclaimers:
The data provided is for informational purposes only and should not be considered investment advice. Market share data is estimated and may not be precise. Financial data is based on publicly available information and may be subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Figs Inc
Exchange NYSE | Headquaters Santa Monica, CA, United States | ||
IPO Launch date 2021-05-27 | Co-Founder, CEO & Director Ms. Catherine Eva Spear | ||
Sector Consumer Cyclical | Industry Apparel Manufacturing | Full time employees 303 | Website https://www.wearfigs.com |
Full time employees 303 | Website https://www.wearfigs.com |
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings and tops, super-soft pima cotton tops, vests, fleeces, and jackets; and necessities comprising scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail stores. FIGS, Inc. was incorporated in 2013 and is headquartered in Santa Monica, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.